Elicera Therapeutics AB (publ) (STO:ELIC)
5.74
-0.76 (-11.69%)
Mar 9, 2026, 5:29 PM CET
143.22% (1Y)
| Market Cap | 315.48M |
| Revenue (ttm) | 10.86M |
| Net Income (ttm) | -17.41M |
| Shares Out | 48.54M |
| EPS (ttm) | -0.38 |
| PE Ratio | n/a |
| Forward PE | 4.41 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 563,842 |
| Average Volume | 281,458 |
| Open | 6.35 |
| Previous Close | 6.50 |
| Day's Range | 5.47 - 6.35 |
| 52-Week Range | 2.12 - 8.43 |
| Beta | 0.41 |
| RSI | 60.67 |
| Earnings Date | Feb 13, 2026 |